Brenda Jean Gehrke - Publications

Affiliations: 
2004 University of Kentucky, Lexington, KY 

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Przepiorka D, Ko CW, Deisseroth A, Yancey CL, Candau-Chacon R, Chiu HJ, Gehrke BJ, Gomez-Broughton C, Kane RC, Kirshner S, Mehrotra N, Ricks TK, Schmiel D, Song P, Zhao P, et al. FDA Approval: Blinatumomab. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 4035-9. PMID 26374073 DOI: 10.1158/1078-0432.CCR-15-0612  1
2015 Deisseroth A, Ko CW, Nie L, Zirkelbach JF, Zhao L, Bullock J, Mehrotra N, Del Valle P, Saber H, Sheth C, Gehrke B, Justice R, Farrell A, Pazdur R. FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 950-4. PMID 25601959 DOI: 10.1158/1078-0432.CCR-14-1678  1
2014 Malik SM, Maher VE, Bijwaard KE, Becker RL, Zhang L, Tang SW, Song P, Liu Q, Marathe A, Gehrke B, Helms W, Hanner D, Justice R, Pazdur R. U.S. Food and Drug Administration approval: crizotinib for treatment of advanced or metastatic non-small cell lung cancer that is anaplastic lymphoma kinase positive. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2029-34. PMID 24573551 DOI: 10.1158/1078-0432.CCR-13-3077  1
2012 Thornton K, Kim G, Maher VE, Chattopadhyay S, Tang S, Moon YJ, Song P, Marathe A, Balakrishnan S, Zhu H, Garnett C, Liu Q, Booth B, Gehrke B, Dorsam R, et al. Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: U.S. Food and Drug Administration drug approval summary. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 3722-30. PMID 22665903 DOI: 10.1158/1078-0432.CCR-12-0411  1
2008 Schepers RJ, Mahoney JL, Gehrke BJ, Shippenberg TS. Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation. Pain. 138: 423-39. PMID 18355964 DOI: 10.1016/j.pain.2008.01.023  1
2008 Gehrke BJ, Chefer VI, Shippenberg TS. Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum. Psychopharmacology. 197: 509-17. PMID 18246329 DOI: 10.1007/s00213-007-1067-6  1
2007 Klein ED, Gehrke BJ, Green TA, Zentall TR, Bardo MT. Repeated Cocaine Experience Facilitates Sucrose-Reinforced Operant Responding in Enriched and Isolated Rats. Learning and Motivation. 38. PMID 24347683 DOI: 10.1016/j.lmot.2006.07.004  1
2006 Gehrke BJ, Cass WA, Bardo MT. Monoamine-depleting doses of methamphetamine in enriched and isolated rats: consequences for subsequent methamphetamine-induced hyperactivity and reward. Behavioural Pharmacology. 17: 499-508. PMID 16940771 DOI: 10.1097/00008877-200609000-00016  1
2003 Gehrke BJ, Harrod SB, Cass WA, Bardo MT. The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats. Psychopharmacology. 166: 249-57. PMID 12589519 DOI: 10.1007/s00213-002-1318-5  1
2003 Bardo MT, Gehrke BJ, Shortridge BE, Rauhut AS. Effects of beta-funaltrexamine and naloxonazine on single-trial morphine-conditioned place preference and locomotor activity. Pharmacology, Biochemistry, and Behavior. 74: 617-22. PMID 12543227 DOI: 10.1016/S0091-3057(02)01049-3  1
2003 Harrod SB, Dwoskin LP, Green TA, Gehrke BJ, Bardo MT. Lobeline does not serve as a reinforcer in rats. Psychopharmacology. 165: 397-404. PMID 12459929 DOI: 10.1007/s00213-002-1289-6  1
2002 Green TA, Gehrke BJ, Bardo MT. Environmental enrichment decreases intravenous amphetamine self-administration in rats: dose-response functions for fixed- and progressive-ratio schedules. Psychopharmacology. 162: 373-8. PMID 12172690 DOI: 10.1007/s00213-002-1134-y  1
2002 Rauhut AS, Gehrke BJ, Phillips SB, Bardo MT. Effects of opioid antagonists on unconditioned and conditioned hyperactivity to morphine. Pharmacology, Biochemistry, and Behavior. 73: 611-22. PMID 12151036 DOI: 10.1016/S0091-3057(02)00855-9  1
Show low-probability matches.